Malaria positivity following a single oral dose of azithromycin among children in Burkina Faso: a randomized controlled trial - BMC Infectious Diseases - BMC Infectious Diseases

  • World Health Organ. WHO World malaria report 2020. Malaria report 2020. Geneva: World Health Organ; 2020. p. 2020.

    Google Scholar 

  • Rowe AK, Rowe SY, Snow RW, Korenromp EL, Armstrong Schellenberg JRM, Stein C, et al. The burden of malaria mortality among African children in the year 2000. Int J Epidemiol. 2006;35:691–704.

    Article  Google Scholar 

  • Baba E, Hamade P, Kivumbi H, Marasciulo M, Maxwell K, Moroso D, et al. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. Lancet. 2020;396:1829–40.

    Article  Google Scholar 

  • Witkowski B, Berry A, Benoit-Vical F. Resistance to antimalarial compounds: methods and applications. Drug Resist Update. 2009;12:42–50.

    CAS  Article  Google Scholar 

  • Burns AL, Sleebs BE, Siddiqui G, De Paoli AE, Anderson D, Liffner B, et al. Retargeting azithromycin analogues to have dual-modality antimalarial activity. BMC Biol. 2020;18(1):133.

    CAS  Article  Google Scholar 

  • Oldenburg CE, Amza A, Cooley G, Kadri B, Nassirou B, Arnold BF, et al. Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial. Malar J. 2019;18:389.

    CAS  Article  Google Scholar 

  • Keenan JD, Bailey RL, West SK, Arzika AM, Hart J, Weaver J, et al. Azithromycin to reduce childhood mortality in Sub-Saharan Africa. N Engl J Med. 2018;378:1583.

    CAS  Article  Google Scholar 

  • Arzika AM, Maliki R, Boubacar N, Kane S, Cotter SY, Lebas E, et al. Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: a cluster-randomized, placebo-controlled trial. PLoS Med. 2019;16:e1002835.

    Article  Google Scholar 

  • FY 2020 Burkina Faso Malaria Operational Plan. www.pmi.gov. Accessed 13 May 2021.

  • De M, Sante LA, Faso B. Avec l'appui de l'UNICEF.

  • Hammer GP, Somé F, Müller O, Kynast-Wolf G, Kouyaté B, Becher H. Pattern of cause-specific childhood mortality in a malaria endemic area of Burkina Faso. Malar J. 2006;5(1):1–8. https://doi.org/10.1186/1475-2875-5-47.

    Article  Google Scholar 

  • Nouna HDSS, Burkina Faso brief description of Nouna HDSS.

  • Mank I, Belesova K, Bliefernicht J, Traoré I, Wilkinson P, Danquah I, et al. The impact of rainfall variability on diets and undernutrition of young children in rural Burkina Faso. Front Public Health. 2021;0:1376.

    Google Scholar 

  • Sié A, Louis V, Gbangou A, Müller O, Niamba L, Stieglbauer G, et al. The health and demographic surveillance system (HDSS) in Nouna, Burkina Faso, 1993–2007. Glob Health Action. 2010;3:5284.

    Article  Google Scholar 

  • Otte Im Kampe E, Müller O, Sie A, Becher H. Seasonal and temporal trends in all-cause and malaria mortality in rural Burkina Faso, 1998–2007. Malar J. 2015;14:300.

    Article  Google Scholar 

  • States Agency for International Development U. PMI VECTORLINK Burkina Faso entomological monitoring annual report, January—December 2019. 2019.

  • Tourre YM, Vignolles C, Viel C, Faruque FS, Malone JB. Malaria in Burkina Faso (West Africa) during the twenty-first century. https://doi.org/10.1007/s10661-019-7410-7.

  • Basilion EV, Kilima PM, Mecaskey JW. Simplification and improvement of height-based azithromycin treatment for paediatric trachoma. Trans R Soc Trop Med Hyg. 2005;99:6–12.

    CAS  Article  Google Scholar 

  • Sié A, Dah C, Bountogo M, Ouattara M, Nebie E, Coulibaly B, et al. Adverse events and clinic visits following a single dose of oral azithromycin among preschool children: a randomized placebo-controlled trial. Am J Trop Med Hyg. 2021;104:1137–41.

    Google Scholar 

  • Oldenburg CE, Arzika AM, Maliki R, Kane MS, Lebas E, Ray KJ, et al. Safety of azithromycin in infants under six months of age in Niger: a community randomized trial. PLoS Negl Trop Dis. 2018;12(11):e0006950.

    CAS  Article  Google Scholar 

  • Ayele B, Gebre T, House JI, Zhou Z, McCulloch CE, Porco TC, et al. Adverse events after mass azithromycin treatments for trachoma in Ethiopia. Am J Trop Med Hyg. 2011;85(2):291–4.

    Article  Google Scholar 

  • Phiri MD, Cairns M, Zongo I, Nikiema F, Diarra M, Yerbanga RS, et al. The duration of protection from azithromycin against malaria, acute respiratory, gastrointestinal, and skin infections when given alongside seasonal malaria chemoprevention: secondary analyses of data from a clinical trial in Houndé, Burkina Faso, and Bou. Clin Infect Dis. 2021;73:e2379–86.

    CAS  Article  Google Scholar 

  • WHO. Burkina Faso world malaria report. 2016. https://www.who.int/malaria/publications/country-profiles/2016/profile_bfa_en.pdf?ua=1. Accessed 14 May 2021.

  • Schachterle SE, Mtove G, Levens JP, Clemens E, Shi L, Raj A, et al. Short-term malaria reduction by single-dose azithromycin during mass drug administration for trachoma, Tanzania. Emerg Infect Dis. 2014;20:941–9.

    CAS  Article  Google Scholar 

  • Chandramohan D, Dicko A, Zongo I, Sagara I, Cairns M, Kuepfer I, et al. Effect of adding azithromycin to seasonal malaria chemoprevention. N Engl J Med. 2019;380:2197–206.

    Article  Google Scholar 

  • Diallo A, Sié A, Sirima S, Sylla K, Ndiaye M, Bountogo M, et al. An epidemiological study to assess Plasmodium falciparum parasite prevalence and malaria control measures in Burkina Faso and Senegal. Malar J. 2017;16:63.

    Article  Google Scholar 

  • Gaynor BD, Amza A, Kadri B, Nassirou B, Lawan O, Maman L, et al. Impact of mass azithromycin distribution on malaria parasitemia during the low-transmission season in Niger: A cluster-randomized trial. Am J Trop Med Hyg. 2014;90(5):846–51.

    CAS  Article  Google Scholar 

  • Porco TC, Gebre T, Ayele B, House J, Keenan J, Zhou Z, et al. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA J Am Med Assoc. 2009;302(9):962–8.

    CAS  Article  Google Scholar 

  • O'Brien KS, Cotter SY, Amza A, Kadri B, Nassirou B, Stoller NE, et al. Mass azithromycin and malaria parasitemia in Niger: results from a community-randomized trial. Am J Trop Med Hyg. 2017;97(3):696–701.

    Article  Google Scholar 

  • Bloch EM, Munoz B, Mrango Z, Weaver J, Mboera LEG, Lietman TM, et al. The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study. Malar J. 2019;18(1):284.

    Article  Google Scholar 

  • Hart JD, Samikwa L, Sikina F, Kalua K, Keenan JD, Lietman TM, et al. Effects of biannual azithromycin mass drug administration on malaria in Malawian children: a cluster-randomized trial. Am J Trop Med Hyg. 2020;103(3):1329–34.

    Article  Google Scholar 

  • Gendrin M, Yerbanga RS, Ouedraogo JB, Lefèvre T, Cohuet A, Christophides GK. Differential effects of azithromycin, doxycycline, and cotrimoxazole in ingested blood on the vectorial capacity of malaria mosquitoes. Open Forum Infect Dis. 2016;3:ofw074.

    Article  Google Scholar 

  • World Health Organ. Antimicrobial resistance. Global report on surveillance. Geneva: World Health Organ; 2014.

    Google Scholar 

  • Tiono AB, Ouédraogo A, Diarra A, Coulibaly S, Soulama I, Konaté AT, et al. Lessons learned from the use of HRP-2 based rapid diagnostic test in community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso. Malar J. 2014;13:30.

    Article  Google Scholar 

  • Watson OJ, Sumner KM, Janko M, Goel V, Winskill P, Slater HC, et al. False-negative malaria rapid diagnostic test results and their impact on community-based malaria surveys in sub-Saharan Africa. BMJ Glob Health. 2019;4:e001582.

    Article  Google Scholar 

  • Plucinski MM, Dimbu PR, Fortes F, Murphy SC, Smith NT, Cruz KR, et al. Malaria parasite density in individuals with different rapid diagnostic test results and concentrations of HRP2 antigen. Am J Trop Med Hyg. 2019;100:1202–3.

    CAS  Article  Google Scholar 

  • Rapp RP. Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions. Ann Pharmacother. 1998;32:785–93.

    CAS  Article  Google Scholar 

    • Comments

    Post a Comment

    Popular posts from this blog

    Tapeworms: How to tell if you have one - Fox News

    Image
    Tapeworms: How to tell if you have one - Fox News Tapeworms: How to tell if you have one - Fox News Posted: 14 Dec 2019 12:00 AM PST A tapeworm is a parasite that you can get if you eat the infected and undercooked meat of an animal. (iStock) Dear Dr. Manny, I ate something on a trip to Brazil and now I've been having terrible stomach issues. I've read about people who have had tapeworms and I don't know if I have one. How do you know if you have a tapeworm? What do the eggs look like? How do you diagnose a tapeworm? Will the worm die on its own? Is it common to get a tapeworm?  Thanks for your question. A tapeworm is a parasite that you can get if you eat the infected and undercooked meat of an animal. So you could have gotten a tapeworm by eating something. It's hard to know if you have a tapeworm on your own, but the most common symptoms are abdominal pain, nausea, diarrhea, unexplained weight los...
    Read more

    What Is Vitiligo? All About This Unique Skin Condition That Impacts Skin Pigmentation, and How To Treat It - Parade Magazine

    Image
    Vitiligo is a condition that causes the skin to begin to lose its pigmentation—or color—for no apparent reason, resulting in white patches that are especially noticeable in people whose skin tone is naturally dark. If you've heard of this chronic skin condition, there's a very good chance it was in association with Michael Jackson. The King of Pop is reported to have had vitiligo—and other celebrities have it as well, including model Winnie Harlow, who has had an empowering presence of showing the condition's unique beauty and style. All in all, though, it's a fairly rare disorder: Approximately .5% to 2% of the world's population has vitiligo, according to a study in Dermatology Reports . What's behind this uncommon disease and is there a treatment for it? Here's what the experts have to say. What Is Vitiligo? What is vitiligo exactly? "Vitiligo is mainly an autoimmune disease of the skin that targets pigment-producing cells called melanocytes," s...
    Read more

    The 18 Best Body Butters to Revive Your Skin for Spring - WWD

    Image
    If you purchase an independently reviewed product or service through a link on our website, WWD may receive an affiliate commission. When you're plagued with dry skin, it can feel like no amount of body lotions or creams are ever moisturizing enough. And you're not imagining things — many hydrating products can just simply sit on the surface of skin, rarely getting absorbed to repair dryness. But that's where body butters save the day. These rich, ultra-concentrated creams can resolve a plethora of concerns, from cracked skin to achy muscles to reducing the appearance of cellulite. But first and foremost, what is body butter?  What is Body Butter? "I like to think it's a descriptive term," says Bee Shapiro , founder of fragrance and body care brand Ellis Brooklyn and New York Times columnist. "It's not a technical term, but we use it to communicate that the texture is extra rich and thick."&...
    Read more